The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-(4-cyclopropy1-3,4-dihydro quinoxalin-1(2H)-yl)(1-(1-phenylethyl)-1H-imidazol-5-yl)methanone ID: ALA4779837
PubChem CID: 155669602
Max Phase: Preclinical
Molecular Formula: C23H24N4O
Molecular Weight: 372.47
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C[C@H](c1ccccc1)n1cncc1C(=O)N1CCN(C2CC2)c2ccccc21
Standard InChI: InChI=1S/C23H24N4O/c1-17(18-7-3-2-4-8-18)27-16-24-15-22(27)23(28)26-14-13-25(19-11-12-19)20-9-5-6-10-21(20)26/h2-10,15-17,19H,11-14H2,1H3/t17-/m1/s1
Standard InChI Key: LRVQGFKSRFYBMY-QGZVFWFLSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
11.6219 -19.1357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9970 -19.6799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1587 -20.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9446 -20.7604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5691 -20.2067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4043 -19.3971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3541 -20.4673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5188 -21.2780 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9566 -21.8853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3669 -22.6065 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1784 -22.4403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2685 -21.6169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9871 -21.2040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9743 -19.9215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9903 -20.3767 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.6988 -21.6177 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6940 -22.4384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4016 -22.8520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1181 -22.4460 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.8283 -22.8610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2350 -23.5766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6514 -22.8666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4105 -21.2037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1215 -21.6220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8371 -21.2155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8430 -20.3908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1273 -19.9744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4145 -20.3833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
9 10 2 0
8 9 1 0
10 11 1 0
11 12 2 0
12 8 1 0
12 13 1 0
7 14 1 1
13 15 2 0
13 16 1 0
16 17 1 0
16 23 1 0
17 18 1 0
18 19 1 0
19 24 1 0
21 20 1 0
22 21 1 0
20 22 1 0
19 20 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 372.47Molecular Weight (Monoisotopic): 372.1950AlogP: 4.12#Rotatable Bonds: 4Polar Surface Area: 41.37Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.50CX LogP: 3.50CX LogD: 3.50Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.69Np Likeness Score: -0.98
References 1. Zhao S,Li X,Wang L,Peng W,Ye W,Li W,Wang YD,Chen WD. (2021) Design, synthesis and evaluation of 1-benzyl-1H-imidazole-5-carboxamide derivatives as potent TGR5 agonists., 32 [PMID:33440321 ] [10.1016/j.bmc.2020.115972 ]